Erratum: Oleoylethanolamideand Human Neural Responses to Food Stimuli in Obesity published in the November issue (JAMA Psychiatry DOI:10.1001/jamapsychiatry.2014.1215);Oleoylethanolamide and human neural responses to food stimuli in obesity

JAMA Psychiatry

Volumn 71, Issue 11, 2014, Pages 1254-1261

  Grosshans, Martin ^a   Schwarz, Emanuel ^a   Bumb, Jan Malte ^a   Schaefer, Carola ^a   Rohleder, Cathrin ^a   Vollmert, Christian ^a   Vollstadt Klein, Sabine ^a   Tost, Heike ^a   Meyer Lindenberg, Andreas ^a   Kiefer, Falk ^a   Leweke, F Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; LEPTIN; N OLEOYLETHANOLAMINE; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; OLEIC ACID;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY HEIGHT; BODY MASS; BRAIN REGION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FOOD INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; INTEROCEPTION; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETRY; NERVE POTENTIAL; NERVE STIMULATION; OBESITY; REWARD; SMOKING; TANDEM MASS SPECTROMETRY; WEIGHT CONTROL; WEIGHT GAIN; BLOOD; BRAIN CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; WITHDRAWAL SYNDROME; YOUNG ADULT;

ADULT; APPETITE REGULATION; ARACHIDONIC ACIDS; BODY MASS INDEX; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CRAVING; ENDOCANNABINOIDS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; LEPTIN; MAGNETIC RESONANCE IMAGING; MALE; OBESITY; OLEIC ACIDS; PHOTIC STIMULATION; POLYUNSATURATED ALKAMIDES; YOUNG ADULT;

EID: 84923668993     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.1215     Document Type: Erratum

References (49)

1. Hyde R. Europe battles with obesity. Lancet. 2008;371(9631):2160-2161.
2. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291(23):2847-2850.
3. FrellickM. AMA declares obesity a disease. www.medscape.com/viewarticle/793269. Published June 20, 2013. Accessed August 25, 2014.
4. Block JP, Subramanian SV, Christakis NA, O'Malley AJ. Population trends and variation in body mass index from 1971 to 2008 in the Framingham Heart Study offspring cohort. PLoS One. 2013;8(5): e63217.
5. Tsai AG,Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142(1):56-66.
6. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci. 2012;13(4):279-286.
7. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12(11):638-651.
8. Rodriguez de Fonseca F, Navarro M, Gomez R, et al. An anorexic lipid mediator regulated by feeding. Nature. 2001;414(6860):209-212.
9. Fu J, Gaetani S, Oveisi F, et al. Oleylethanolamide regulates feeding and bodyweight through activation of the nuclear receptor PPAR-alpha. Nature. 2003; 425(6953):90-93.
10. Evans RM, Barish GD,Wang Y-X. PPARs and the complex journey to obesity. Nat Med. 2004;10(4): 355-361.
11. Lefebvre P, Chinetti G, Fruchart J-C, Staels B. Sorting out the roles of PPAR in energy metabolism and vascular homeostasis. J Clin Invest. 2006;116(3): 571-580.
12. Walter L, Franklin A, Witting A, Moller T, Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem. 2002;277 (23):20869-20876.
13. Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372(6507):686-691.
14. Cadas H, di Tomaso E, Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J Neurosci. 1997;17(4):1226-1242.
15. Schwartz GJ, Fu J, Astarita G, et al. The lipid messenger oleoylethanolamide links dietary fat intake to satiety. Cell Metab. 2008;8(4):281-288.
16. Oveisi F, Gaetani S, Eng KT-P, Piomelli D. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol Res. 2004;49(5):461-466.
17. Fu J, Kim J, Oveisi F, Astarita G, Piomelli D. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am J Physiol Regul Integr Comp Physiol. 2008;295(1):R45-R50.
18. Proulx K, Cota D, Castaneda TR, et al. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity.AmJPhysiol Regul Integr Comp Physiol. 2005;289(3):R729-R737.
19. Piomelli D. A fatty gut feeling. Trends Endocrinol Metab. 2013;24(7):332-341.
20. Tellez LA, Medina S, HanW, et al. A gut lipid messenger links excess dietary fat to dopamine deficiency. Science. 2013;341(6147):800-802.
21. Grosshans M, Vollmert C, Vollstadt-Klein S, et al. Association of leptin with food cue-induced activation in human reward pathways. Arch Gen Psychiatry. 2012;69(5):529-537.
22. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland:World Health Organization; 1998.
23. Lang P, Bradley M, Cuthbert B. The International Affective Picture System (IAPS). Gainesville: Center for Research in Psychophysiology, University of Florida; 1999.
24. Tang DW, Fellows LK, Small DM, Dagher A. Food and drug cues activate similar brain regions: ameta-analysis of functional MRI studies. Physiol Behav. 2012;106(3):317-324.
25. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1): 273-289.
26. David SP, MunafoMR, Johansen-Berg H, et al. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;58(6):488-494.
27. Kersten S, Desvergne B,WahliW. Roles of PPARs in health and disease. Nature. 2000;405 (6785):421-424.
28. JunM, Foote C, Lv J, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010;375(9729):1875-1884.
29. Mancini FP, Lanni A, Sabatino L, et al. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett. 2001;491(1-2):154-158.
30. Carmona MC, Louche K, NibbelinkM, et al. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice. Int J Obes (Lond). 2005; 29(7):864-871.
31. Panlilio LV, Justinova Z, Mascia P, et al. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology. 2012;37(8):1838-1847.
32. Aviello G, Matias I, Capasso R, et al. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med (Berl). 2008;86(4):413-422.
33. Izzo AA, Piscitelli F, Capasso R, et al. Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obesity (Silver Spring). 2010;18(1):55-62.
34. Annuzzi G, Piscitelli F, Di Marino L, et al. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Lipids Health Dis. 2010;9:43.
35. Matias I, Gonthier M-P, Petrosino S, et al. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol. 2007;152(5):676-690.
36. Engeli S, Bohnke J, Feldpausch M, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54(10): 2838-2843.
37. Di Marzo V, Despres J-P. CB1 antagonists for obesity: what lessons have we learned from rimonabant? Nat Rev Endocrinol. 2009;5(11): 633-638.
38. Flynn FG. Anatomy of the insula functional and clinical correlates. Aphasiology. 1999;13(1):55-78.
39. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453-466.
40. Faurion A, Cerf B, Van De Moortele PF, Lobel E, Mac Leod P, Le Bihan D. Human taste cortical areas studied with functionalmagnetic resonance imaging: evidence of functional lateralization related to handedness. Neurosci Lett. 1999;277(3):189-192.
41. SchoenfeldMA, Neuer G, Tempelmann C, et al. Functional magnetic resonance tomography correlates of taste perception in the human primary taste cortex. Neuroscience. 2004;127(2):347-353.
42. Scott TR, Yaxley S, Sienkiewicz ZJ, Rolls ET. Gustatory responses in the frontal opercular cortex of the alert cynomolgus monkey. J Neurophysiol. 1986;56(3):876-890.
43. GrayMA, Critchley HD. Interoceptive basis to craving. Neuron. 2007;54(2):183-186.
44. Small DM. Central gustatory processing in humans. Adv Otorhinolaryngol. 2006;63:191-220.
45. Simmons WK, Rapuano KM, Kallman SJ, et al. Category-specific integration of homeostatic signals in caudal but not rostral human insula. Nat Neurosci. 2013;16(11):1551-1552.
46. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol. 2008;117(4):924-935.
47. Oberndorfer TA, Frank GKW, Simmons AN, et al. Altered insula response to sweet taste processing after recovery from anorexia and bulimia nervosa.AmJ Psychiatry. 2013;170(10):1143-1151.
48. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007;315(5811):531-534.
49. Monteleone P, Piscitelli F, Scognamiglio P, et al. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. J Clin Endocrinol Metab. 2012;97(6):917-924.